- Home
- GEVO vs GDEV Comparison
GEVO vs GDEV Comparison
Compare GEVO & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- GDEV
- Stock Information
- Founded
- GEVO 2005
- GDEV 2009
- Country
- GEVO United States
- GDEV Cyprus
- Employees
- GEVO N/A
- GDEV N/A
- Industry
- GEVO Major Chemicals
- GDEV EDP Services
- Sector
- GEVO Industrials
- GDEV Technology
- Exchange
- GEVO Nasdaq
- GDEV Nasdaq
- Market Cap
- GEVO 285.1M
- GDEV N/A
- IPO Year
- GEVO 2011
- GDEV N/A
- Fundamental
- Price
- GEVO $1.14
- GDEV $15.45
- Analyst Decision
- GEVO Buy
- GDEV Buy
- Analyst Count
- GEVO 2
- GDEV 2
- Target Price
- GEVO $7.58
- GDEV $70.00
- AVG Volume (30 Days)
- GEVO 2.4M
- GDEV 37.4K
- Earning Date
- GEVO 05-13-2025
- GDEV 05-27-2025
- Dividend Yield
- GEVO N/A
- GDEV N/A
- EPS Growth
- GEVO N/A
- GDEV N/A
- EPS
- GEVO N/A
- GDEV 1.38
- Revenue
- GEVO $16,915,000.00
- GDEV $420,933,000.00
- Revenue This Year
- GEVO $617.82
- GDEV $4.73
- Revenue Next Year
- GEVO $84.22
- GDEV $16.15
- P/E Ratio
- GEVO N/A
- GDEV $11.17
- Revenue Growth
- GEVO N/A
- GDEV N/A
- 52 Week Low
- GEVO $0.48
- GDEV $8.60
- 52 Week High
- GEVO $3.39
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- GEVO 49.70
- GDEV 62.08
- Support Level
- GEVO $1.00
- GDEV $10.25
- Resistance Level
- GEVO $1.14
- GDEV $18.33
- Average True Range (ATR)
- GEVO 0.08
- GDEV 1.43
- MACD
- GEVO 0.00
- GDEV 0.79
- Stochastic Oscillator
- GEVO 60.87
- GDEV 64.36
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.